Medical device maker plans Warsaw expansion
Biomet could add about 280 jobs with the $26 million project, which would lead to some manufacturing being transferred from
New Jersey.
Health Care & Life Sciences
Articles
Shifts at state hospitals to cut 500-plus jobs
The Logansport State Hospital will have 355 workers laid off and 80 vacant positions eliminated under the plan, while 106
people will lose jobs at the Richmond State Hospital.
Diagnostics division to help Lilly tailor treatments
Eli Lilly and Co. is launching a diagnostics division to produce tests that can winnow out the patients most likely to benefit
from a Lilly drug.
Home medical supply firm grows as industry boom approaches
David Hartley pulled $85,000 from his savings six years ago to buy Home Health Depot Inc. Nearly six years later, Hartley
has reinvented the Indianapolis-based home medical equipment supplier, growing from a single office in Greenwood to 12 locations
in Indiana and Illinois—and increasing annual revenue from $300,000 to more than $6.7 million.
Hospitals see dip in charity care after 2008
Unemployment in Indiana has moderated slightly, but more than 313,000 Hoosiers remain out of work. And with attempts to extend
benefits for the jobless stalled in Congress, it’s likely more people will struggle to pay medical bills.
PROXY CORNER: Baldwin & Lyons Inc.
Baldwin & Lyons Inc. provides property-and-casualty insurance for various industries, including trucking.
Regenstrief names new CEO
Dr. Bill Tierney will replace Dr. Tom Inui on Oct. 1 at helm of Indianapolis-based medical research organization.
Medical device firm eyeing Indianapolis growth
Greatbatch Medical wants to expand its facility on the east side of Indianapolis to accommodate its entrance into the orthopedics
market. The
New York-based company specializes in cardiovascular products.
Lilly’s Lechleiter: No change in plans
The global financial press keeps asking John Lechleiter for his end-game strategy to survive Eli Lilly and Co.'s nightmarish
patent challenges. And, like a broken record, the Lilly CEO keeps giving the same answer: pipeline, pipeline, pipeline—no
mega-merger.
Health reform rule could cost WellPoint
WellPoint Inc. has about $800 million riding on one arcane rule: how to calculate a medical loss ratio. The ratio quantifies
the percentage of customers’ premiums were spent on medical care, rather than overhead or profits.
Men on Viagra, Cialis show triple rate of sex diseases in study
The findings suggest that users of drugs to treat erectile dysfunction, including Eli Lilly’s Cialis, may be more likely to
engage in unsafe sex than nonusers.
Fort Wayne medical practice splits, following industry trend
More than 100 staff members of Indiana Medical Associates LLC likely will land at one of two area hospital systems. The move
mirrors national and local consolidation of practices with hospitals.
Connecticut to probe WellPoint security breach
Attorney general seeks more details on the breach, which may have compromised financial and health information on almost 500,000
people. He also calls on the Indianapolis-based insurer to provide affected customers with credit monitoring and theft protection
services.
Widowed car dealer Christine Burd becomes mental health advocate
Burd, who is president of Burd Ford, a mother of four, and a fixture on television commercials for the dealership, has become
an advocate for mental health following her husband’s suicide.
Wishard construction bids starting to flow
About $72 million in bids have been awarded so far for the $754 million Wishard Hospital project—ahead of schedule
and under budget, for the time being—including demolition and foundation work.
Lilly acquires biotech company with pancreatic drug
Massachusetts-based Alnara Pharmaceuticals Inc., which has attracted $55 million in venture capital in the past two years,
recently submitted its drug to the FDA for market approval.
Program tying doctor bonuses to quality goes statewide
The program currently includes 1,200 physicians—about 10 percent of all doctors in Indiana.
Grassley asks Lilly, peers about whistleblower treatment
U.S. Senator Charles Grassley asked 16 drugmakers, including Eli Lilly & Co., Pfizer Inc. and AstraZeneca Plc, to reveal
how they treat whistleblowers who file complaints under the False Claims Act.
WellPoint seeking 14 percent rate hike in California
Indianapolis-based WellPoint Inc. said Wednesday that its California subsidiary will dial down rate hikes that drew national outrage earlier this year and helped spark a final push for health care reform.
Health care reform bringing changes to Caregivers
Caregivers anticipates coping with declining Medicare reimbursements while having to offer insurance to its employees.